dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Martín Liberal, Juan Jesús |
dc.contributor.author | Hollebecque, Antoine |
dc.contributor.author | Jungels, Christiane |
dc.contributor.author | Martin-Romano, Patricia |
dc.contributor.author | Rodon Ahnert, Jordi |
dc.contributor.author | Aftimos, Philippe |
dc.date.accessioned | 2021-11-11T10:02:38Z |
dc.date.available | 2021-11-11T10:02:38Z |
dc.date.issued | 2020-10 |
dc.identifier.citation | Martin-Liberal J, Hollebecque A, Aftimos P, Jungels C, Martin-Romano P, Rodon J, et al. First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours. Br J Cancer. 2020 Oct;123:1235–43. |
dc.identifier.issn | 1532-1827 |
dc.identifier.uri | https://hdl.handle.net/11351/6529 |
dc.description | Desarrollo de fármacos |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | British Journal of Cancer;123 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Quimioteràpia |
dc.subject | Quimioteràpia combinada |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.title | First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41416-020-1011-7 |
dc.subject.decs | neoplasias |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://doi.org/10.1038/s41416-020-1011-7 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Martin-Liberal J] Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Medical Oncology, Catalan Institute of Oncology (ICO), Barcelona, Spain. [Hollebecque A, Martin-Romano P] Department of Adult Medicine, Gustave Roussy, Paris, France. [Aftimos P, Jungels C] Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. [Rodon J] Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 32741971 |
dc.identifier.wos | 000554842400005 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |